Headquartered in New Delhi, UniMedNTech has rapidly evolved from a dynamic startup into a trusted leader in cancer care, healthcare facilitation and strategic business development consultancy services.

We partner with State and Central Governments under the National Health Mission to design and implement large scale screening programmes for Cancer, Tuberculosis, and Sickle Cell Disease, ensuring early detection and improved health outcomes across communities nationwide.

Beyond public health, UniMedNTech delivers strategic consultancy and liaison services to domestic and international corporations across diverse sectors including healthcare, pharmaceuticals, medical education, agriculture, forestry, infrastructure, and power.

In the specialised domain of name patient medicines, we exclusively facilitate access to USFDA and European FDA approved therapies not yet authorised by the DCGI. This enables Indian patients to receive urgently needed treatments for cancer, HIV, and other life threatening conditions.

With an unwavering commitment to compliance, innovation, and patient centric solutions, UniMedNTech continues to strengthen India’s healthcare ecosystem and expand access to critical care.